Advanced rectal cancer protocol is promising, study shows

04/3/2013 | Medscape (free registration)

A novel treatment for advanced rectal cancer that includes short-term radiation and systemic chemotherapy followed by surgery shows promise and even curative potential for a condition that experts say currently lacks a standard of care. Dutch researchers reported that the novel protocol led to a two-year survival rate of 80%.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA